Ventyx Biosciences
VTYX
VTYX was delisted on the 3rd of March, 2026.
126 hedge funds and large institutions have $1.4B invested in Ventyx Biosciences in 2022 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 55 increasing their positions, 21 reducing their positions, and 15 closing their positions.
1,551% more call options, than puts
Call options by funds: $1.62M | Put options by funds: $98K
162% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 21
147% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 15
21% more funds holding
Funds holding: 104 → 126 (+22)
2% more capital invested
Capital invested by funds: $1.37B → $1.4B (+$26.6M)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
1.82% less ownership
Funds ownership: 77.16% → 75.34% (-1.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$62.6M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$38.1M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$33.2M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$30.2M |
| 5 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$23.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TP
Third Point
New York
|
-$98.1M |
| 2 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
-$48.9M |
| 3 |
VP
venBio Partners
San Francisco,
California
|
-$45.9M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$21.9M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$13.9M |
VTYX Hedge Fund Activity: Q4 2022 in Review
126 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q4 2022, worth a combined $1.4B — up 1.9% from $1.37B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new VTYX positions and 15 closed out — a net gain of 22 holders — while 55 added to existing stakes and 21 trimmed.
The largest buyer was Capital International Investors, opening a new position worth an estimated $62.6M. The largest seller was Third Point, cutting an estimated $98.1M.
- 126 institutional investors held Ventyx Biosciences (VTYX) as of Q4 2022, up from 104 in Q3 2022.
- Funds reported $1.4B of Ventyx Biosciences stock for Q4 2022, up 1.9% quarter-over-quarter.
- 37 funds opened new Ventyx Biosciences positions in Q4 2022 and 15 closed out, a net change of +22 holders.
- The largest Ventyx Biosciences buyer in Q4 2022 was Capital International Investors, an estimated $62.6M added.
- The largest Ventyx Biosciences seller in Q4 2022 was Third Point, an estimated $98.1M sold.
Based on aggregated 13F filings for Q4 2022.